Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 36921

Reversal of carboplatin resistance in human laryngeal carcinoma cells


Vuković, Lidija; Osmak, Maja
Reversal of carboplatin resistance in human laryngeal carcinoma cells // Neoplasma, 46 (1999), 6; 335-341 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 36921 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Reversal of carboplatin resistance in human laryngeal carcinoma cells

Autori
Vuković, Lidija ; Osmak, Maja

Izvornik
Neoplasma (0028-2685) 46 (1999), 6; 335-341

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
drug resistance; carboplatin; reversal; laryngeal carcinoma cells
(drug resistance;carboplatin; reversal; laryngeal carcinoma cells)

Sažetak
The effectiveness of carboplatin in the treatment of patients with tumors is limited by drug resistance. Because of that, there is a great interest to find a way to revert the resistance and improve the success of cancer treatment. The aim of present study was to examine five potential modulators of carboplatin resistance with different mode of action: buthionine sulphoximine, ethacrinic acid, amphotericine B, cyclosporine A and aphidicoline. The effect of these compounds on the sensitivity of human laryngeal parental (HEp2) and carboplatin-resistant (HEp7T) cells to carboplatin was examined by MTT spectrophotometric assay. The results have shown that buthionin sulphoximine and, to a lesser extent, ethacrinic acid reduced the resistance of HEp7T cells to carboplatin. Aphidicolin increased the sensitivity of both HEp2 and HEp7T cells to carboplatin, but this effect was more expressed in parental HEp2 cells. Our data suggest that human laryngeal carcinoma cells treated with clinically relevant doses of carboplatin became resistant to this drug due to multifactorial molecular mechanisms. Accordingly, the resistance to carboplatin could be reduced by different modulators.

Izvorni jezik
Engleski

Znanstvena područja
Biologija



POVEZANOST RADA


Projekti:
00981008

Ustanove:
Institut "Ruđer Bošković", Zagreb

Profili:

Avatar Url Maja Osmak (autor)

Avatar Url Lidija Vuković (autor)


Citiraj ovu publikaciju:

Vuković, Lidija; Osmak, Maja
Reversal of carboplatin resistance in human laryngeal carcinoma cells // Neoplasma, 46 (1999), 6; 335-341 (međunarodna recenzija, članak, znanstveni)
Vuković, L. & Osmak, M. (1999) Reversal of carboplatin resistance in human laryngeal carcinoma cells. Neoplasma, 46 (6), 335-341.
@article{article, author = {Vukovi\'{c}, Lidija and Osmak, Maja}, year = {1999}, pages = {335-341}, keywords = {drug resistance, carboplatin, reversal, laryngeal carcinoma cells}, journal = {Neoplasma}, volume = {46}, number = {6}, issn = {0028-2685}, title = {Reversal of carboplatin resistance in human laryngeal carcinoma cells}, keyword = {drug resistance, carboplatin, reversal, laryngeal carcinoma cells} }
@article{article, author = {Vukovi\'{c}, Lidija and Osmak, Maja}, year = {1999}, pages = {335-341}, keywords = {drug resistance, carboplatin, reversal, laryngeal carcinoma cells}, journal = {Neoplasma}, volume = {46}, number = {6}, issn = {0028-2685}, title = {Reversal of carboplatin resistance in human laryngeal carcinoma cells}, keyword = {drug resistance, carboplatin, reversal, laryngeal carcinoma cells} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Uključenost u ostale bibliografske baze podataka::


  • CC
  • SCI





Contrast
Increase Font
Decrease Font
Dyslexic Font